Wolfgang Schmitt

16PUBLICATIONS
105CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 09, 2026
Immune evasion in locally advanced mismatch repair-deficient microsatellite instability-high colorectal cancer: Reduced T-cell infiltration and upregulation of epithelial IDO1 expression.

|Jun 02, 2026
Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma.

|Nov 13, 2025
Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets.

Anuar Makhmut, Mihnea P Dragomir, Sonja Fritzsche

|Jul 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer.

Sofya Marchenko, Niklas Goernitz, Wiebke A Zoern

|May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.

Nicole Concin, Ioana Braicu, Pierre Combe

|Feb 25, 2025
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.

Peter A Fasching, Sabine Schmatloch, Jan Hauke

Pageof 3

Frequent Collaborators

5 joint publications

Peter A Fasching

4 joint publications

Eliane Tabea Taube

4 joint publications

Carsten Denkert

3 joint publications

Thomas Karn